US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Envoy Medical Inc.

0.7200

+0.02403.45%

Volume:16.46K

Turnover:11.85K

Market Cap:55.35M

PE:-0.53

High:0.7200

Open:0.7200

Low:0.7200

Close:0.6960

52wk High:1.91

52wk Low:0.3625

Shares:76.88M

Float Shares:18.01M

Volume Ratio:8.37

T/O Rate:0.09%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.3638

EPS(LYR):-1.4887

ROE:--

ROA:-145.31%

PB:-7.35

PE(LYR):-0.48

Loading ...

Overview Company News Filings

Envoy Medical Regains Nasdaq Listing Compliance Under Rule 5550(b)

Envoy Medical Secures Three New Patents for Fully Implanted Cochlear Implant Technology

Envoy Medical Hosts Fireside Chat With Cochlear Implant Surgeon Theodore McRackan

Glen Taylor Buys 241% More Envoy Medical Shares

Simply Wall St.

Envoy Medical Director Mona Chetan Patel Reports Acquisition of Common Shares

Interim CFO Robert Potashnick Acquires Common Shares of Envoy Medical Inc

Envoy Medical Director Susan Kantor Reports Acquisition of Common Shares

Envoy Medical CEO Brent T. Lucas Acquires Common Shares

Envoy Medical Nears Full Enrollment in Pivotal Acclaim Cochlear Implant Trial

Envoy Medical Raises $30 Million in Public Offering With Warrants for Up to $48 Million More

Envoy Medical Awards Stock Options to CEO and Interim CFO at $0.53 Per Share

Envoy Medical Announces Upsized Offering With Warrants for Up to $48 Million in Additional Proceeds

Envoy Medical to Present at Small Cap Growth Virtual Investor Conference

Envoy Medical Hits Enrollment Milestone in Pivotal Acclaim Cochlear Implant Trial

Envoy Medical Secures Australian Patent for Fully Implanted Cochlear Implant Innovation

Envoy Medical Activates First Patients in Pivotal Trial of Fully Implanted Acclaim Cochlear Implant

Envoy Medical Inc. Held Special Meeting of Stockholders

Envoy Medical Inc. Granted 40th U.S. Patent for Fully Implanted Hearing Device Technology

Envoy Medical Faces Nasdaq Delisting Risk Over Minimum Bid Price Compliance

Envoy Medical Granted U.S. Patent for Innovative Cochlear Implant System with Removable Earplug Sensor and Implanted Battery

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/COCH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"COCH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COCH\",,,,,undefined,":{"symbol":"COCH","market":"US","secType":"STK","nameCN":"Envoy Medical Inc.","latestPrice":0.72,"timestamp":1771943400361,"preClose":0.696,"halted":0,"volume":16458,"delay":0,"changeRate":0.03448275862068969,"floatShares":18008500,"shares":76881100,"eps":-1.363837,"marketStatus":"Trading","change":0.024,"latestTime":"02-24 09:30:17 EST","open":0.72,"high":0.72,"low":0.72,"amount":11849.76,"amplitude":0,"askPrice":0.7299,"askSize":298,"bidPrice":0.6924,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-1.363837,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1771966800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.696,"preHourTrading":{"tag":"盘前","latestPrice":0.6999,"preClose":0.696,"latestTime":"09:17 EST","volume":8175,"amount":5817.73875,"timestamp":1771942650035,"change":0.0039,"changeRate":0.005603,"amplitude":0.028879},"postHourTrading":{"tag":"盘后","latestPrice":0.6802,"preClose":0.696,"latestTime":"19:55 EST","volume":929,"amount":626.7136,"timestamp":1771894544935,"change":-0.0158,"changeRate":-0.022701,"amplitude":0.010632},"volumeRatio":8.368874},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COCH\",,,,,undefined,":{"symbol":"COCH","floatShares":18008500,"roa":"-145.31%","roe":"--","lyrEps":-1.488681,"volumeRatio":8.368874,"shares":76881100,"dividePrice":0,"high":0.72,"amplitude":0,"preClose":0.696,"low":0.72,"week52Low":0.3625,"pbRate":"-7.35","psRate":"266.13","week52High":1.91,"institutionHeld":0,"latestPrice":0.72,"committee":-0.497487,"eps":-1.363837,"divideRate":0,"volume":16458,"delay":0,"ttmEps":-1.363837,"open":0.72,"prevYearClose":0.6611,"prevWeekClose":0.7102,"prevMonthClose":0.6499,"prevQuarterClose":0.6611,"fiveDayClose":0.6889,"twentyDayClose":0.679,"sixtyDayClose":0.7989},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COCH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-10","symbol":"COCH","fiscalQuarterEnding":"2025/09","expectedEps":-0.27,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2025-07-31","symbol":"COCH","fiscalQuarterEnding":"2025/06","expectedEps":-0.29,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1753934400000,"reportTimeType":"pre","actualEps":-0.32}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COCH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"COCH\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/COCH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"COCH","date":"2026-02-20","current":-0.510325,"percent":0.188849,"low":-5.350942,"twenty":-2.420786,"median":-1.496566,"eighty":-0.941348,"high":-0.457484,"avg":-1.840237,"sd":1.120617,"marketCap":56507615},"quantilePoints":[{"date":"2023-10-20","current":-0.862855,"twenty":-0.980129,"median":-0.936152,"eighty":-0.892174,"marketCap":33923128},{"date":"2023-10-27","current":-0.56191,"twenty":-0.921492,"median":-0.846644,"eighty":-0.723024,"marketCap":22091479},{"date":"2023-11-03","current":-0.606664,"twenty":-0.843402,"median":-0.621582,"eighty":-0.602686,"marketCap":23850978},{"date":"2023-11-10","current":-0.472402,"twenty":-0.749876,"median":-0.601691,"eighty":-0.51815,"marketCap":18572482},{"date":"2023-11-17","current":-0.472402,"twenty":-0.651418,"median":-0.522128,"eighty":-0.472998,"marketCap":18572482},{"date":"2023-11-24","current":-0.658735,"twenty":-0.643874,"median":-0.522128,"eighty":-0.478269,"marketCap":24046477},{"date":"2023-12-01","current":-1.205004,"twenty":-0.79603,"median":-0.579314,"eighty":-0.486255,"marketCap":43987459},{"date":"2023-12-08","current":-1.065759,"twenty":-0.982212,"median":-0.606688,"eighty":-0.487287,"marketCap":38904464},{"date":"2023-12-15","current":-1.183582,"twenty":-1.025567,"median":-0.614147,"eighty":-0.487322,"marketCap":43205460},{"date":"2023-12-22","current":-1.205004,"twenty":-1.125741,"median":-0.658735,"eighty":-0.492322,"marketCap":43987459},{"date":"2023-12-29","current":-0.98007,"twenty":-1.149306,"median":-0.677453,"eighty":-0.507218,"marketCap":35776467},{"date":"2024-01-05","current":-1.017559,"twenty":-1.132168,"median":-0.744425,"eighty":-0.515106,"marketCap":37144965},{"date":"2024-01-12","current":-0.685513,"twenty":-1.097893,"median":-0.784591,"eighty":-0.520546,"marketCap":25023976},{"date":"2024-01-19","current":-0.760491,"twenty":-1.062556,"median":-0.763169,"eighty":-0.522128,"marketCap":27760974},{"date":"2024-01-26","current":-0.70158,"twenty":-1.043309,"median":-0.744425,"eighty":-0.524814,"marketCap":25610476},{"date":"2024-02-02","current":-0.642669,"twenty":-1.016488,"median":-0.72568,"eighty":-0.540828,"marketCap":23459978},{"date":"2024-02-09","current":-0.734999,"twenty":-1.011652,"median":-0.728358,"eighty":-0.568872,"marketCap":26830395},{"date":"2024-02-16","current":-0.669447,"twenty":-1.005715,"median":-0.723002,"eighty":-0.598707,"marketCap":24437477},{"date":"2024-02-23","current":-0.648024,"twenty":-0.990781,"median":-0.722172,"eighty":-0.606664,"marketCap":23655478},{"date":"2024-03-01","current":-2.522475,"twenty":-1.009448,"median":-0.721342,"eighty":-0.606713,"marketCap":92080415},{"date":"2024-03-08","current":-4.118435,"twenty":-1.065759,"median":-0.723002,"eighty":-0.610535,"marketCap":150339361},{"date":"2024-03-15","current":-2.20114,"twenty":-1.205004,"median":-0.733713,"eighty":-0.621246,"marketCap":80350426},{"date":"2024-03-22","current":-2.072607,"twenty":-1.242493,"median":-0.741747,"eighty":-0.621582,"marketCap":75658430},{"date":"2024-03-28","current":-2.094029,"twenty":-1.895873,"median":-0.755135,"eighty":-0.638452,"marketCap":76440429},{"date":"2024-04-05","current":-3.138365,"twenty":-2.0951,"median":-0.771202,"eighty":-0.642669,"marketCap":114562894},{"date":"2024-04-12","current":-3.984482,"twenty":-2.188287,"median":-0.821545,"eighty":-0.646953,"marketCap":119167890},{"date":"2024-04-19","current":-3.3488,"twenty":-2.453924,"median":-0.835469,"eighty":-0.656593,"marketCap":100155908},{"date":"2024-04-26","current":-3.316033,"twenty":-3.138365,"median":-0.926514,"eighty":-0.658735,"marketCap":99175908},{"date":"2024-05-03","current":-3.178411,"twenty":-3.186275,"median":-0.98007,"eighty":-0.66302,"marketCap":95059912},{"date":"2024-05-10","current":-2.195397,"twenty":-3.146374,"median":-1.010825,"eighty":-0.668376,"marketCap":65659939},{"date":"2024-05-17","current":-2.581982,"twenty":-3.138365,"median":-1.049746,"eighty":-0.669447,"marketCap":59191945},{"date":"2024-05-24","current":-2.607631,"twenty":-2.975556,"median":-1.130026,"eighty":-0.673731,"marketCap":59779945},{"date":"2024-05-31","current":-2.056181,"twenty":-2.915842,"median":-1.194293,"eighty":-0.674802,"marketCap":47137956},{"date":"2024-06-07","current":-1.812517,"twenty":-2.871711,"median":-1.205004,"eighty":-0.681229,"marketCap":41551961},{"date":"2024-06-14","current":-2.299845,"twenty":-2.824526,"median":-1.242493,"eighty":-0.686713,"marketCap":52723951},{"date":"2024-06-21","current":-2.051906,"twenty":-2.782179,"median":-1.478138,"eighty":-0.688983,"marketCap":47039956},{"date":"2024-06-28","current":-1.957861,"twenty":-2.776126,"median":-1.786869,"eighty":-0.689926,"marketCap":44883958},{"date":"2024-07-05","current":-2.000609,"twenty":-2.733159,"median":-1.879806,"eighty":-0.69299,"marketCap":45863957},{"date":"2024-07-12","current":-1.97496,"twenty":-2.670243,"median":-1.932212,"eighty":-0.696192,"marketCap":45275958},{"date":"2024-07-15","current":-2.043357,"twenty":-2.666472,"median":-1.940762,"eighty":-0.696203,"marketCap":46843956},{"date":"2024-08-02","current":-1.96641,"twenty":-2.6627,"median":-1.949312,"eighty":-0.696213,"marketCap":45079958},{"date":"2024-08-09","current":-2.051906,"twenty":-2.617891,"median":-1.957861,"eighty":-0.696224,"marketCap":47039956},{"date":"2024-08-16","current":-3.750569,"twenty":-2.7731,"median":-1.963275,"eighty":-0.696224,"marketCap":50763953},{"date":"2024-08-23","current":-3.970054,"twenty":-2.975556,"median":-1.981562,"eighty":-0.700509,"marketCap":54095950},{"date":"2024-08-30","current":-4.300891,"twenty":-3.226906,"median":-1.99215,"eighty":-0.70158,"marketCap":58603946},{"date":"2024-09-06","current":-4.473502,"twenty":-3.312101,"median":-2.000609,"eighty":-0.70158,"marketCap":60955944},{"date":"2024-09-13","current":-4.811532,"twenty":-3.364528,"median":-2.000609,"eighty":-0.713437,"marketCap":65561939},{"date":"2024-09-20","current":-4.588576,"twenty":-3.74188,"median":-2.021983,"eighty":-0.722338,"marketCap":62523942},{"date":"2024-09-27","current":-4.876261,"twenty":-3.933938,"median":-2.034807,"eighty":-0.723002,"marketCap":66443938},{"date":"2024-10-04","current":-4.373081,"twenty":-3.989387,"median":-2.051906,"eighty":-0.723002,"marketCap":59587595},{"date":"2024-10-11","current":-4.054512,"twenty":-4.031318,"median":-2.056181,"eighty":-0.726216,"marketCap":55246777},{"date":"2024-10-18","current":-3.953149,"twenty":-4.021044,"median":-2.075081,"eighty":-0.731571,"marketCap":53865608},{"date":"2024-10-25","current":-3.63458,"twenty":-4.013314,"median":-2.094029,"eighty":-0.734485,"marketCap":49524789},{"date":"2024-10-31","current":-3.576659,"twenty":-4.006171,"median":-2.103204,"eighty":-0.736627,"marketCap":48735550},{"date":"2024-11-08","current":-2.954001,"twenty":-3.997991,"median":-2.152012,"eighty":-0.741211,"marketCap":40251223},{"date":"2024-11-15","current":-3.084325,"twenty":-3.99184,"median":-2.169007,"eighty":-0.746567,"marketCap":42027012},{"date":"2024-11-22","current":-2.115049,"twenty":-3.983533,"median":-2.152012,"eighty":-0.754064,"marketCap":44538703},{"date":"2024-11-29","current":-2.19196,"twenty":-3.981274,"median":-2.137093,"eighty":-0.761562,"marketCap":46158292},{"date":"2024-12-06","current":-2.076594,"twenty":-3.976354,"median":-2.124663,"eighty":-0.766918,"marketCap":43728908},{"date":"2024-12-13","current":-1.999683,"twenty":-3.966673,"median":-2.115049,"eighty":-0.771738,"marketCap":42109319},{"date":"2024-12-20","current":-1.76895,"twenty":-3.953149,"median":-2.103204,"eighty":-0.78277,"marketCap":37250551},{"date":"2024-12-27","current":-1.653584,"twenty":-3.953149,"median":-2.095821,"eighty":-0.818331,"marketCap":34821167},{"date":"2025-01-03","current":-1.480534,"twenty":-3.941565,"median":-2.090542,"eighty":-0.823473,"marketCap":31177092},{"date":"2025-01-10","current":-1.442079,"twenty":-3.921384,"median":-2.076594,"eighty":-0.828163,"marketCap":30367297},{"date":"2025-01-17","current":-1.442079,"twenty":-3.903517,"median":-2.069794,"eighty":-0.833455,"marketCap":30367297},{"date":"2025-01-24","current":-1.490148,"twenty":-3.88608,"median":-2.06698,"eighty":-0.846423,"marketCap":31379540},{"date":"2025-01-31","current":-1.567155,"twenty":-3.855998,"median":-2.057366,"eighty":-0.87975,"marketCap":33001154},{"date":"2025-02-07","current":-1.499762,"twenty":-3.806073,"median":-2.054043,"eighty":-0.92223,"marketCap":31581989},{"date":"2025-02-14","current":-1.39401,"twenty":-3.752802,"median":-2.051906,"eighty":-0.95222,"marketCap":29355054},{"date":"2025-02-21","current":-1.465152,"twenty":-3.747673,"median":-2.034807,"eighty":-0.962932,"marketCap":30853174},{"date":"2025-02-28","current":-1.269029,"twenty":-3.736059,"median":-2.022584,"eighty":-0.982212,"marketCap":26723221},{"date":"2025-03-07","current":-1.314662,"twenty":-3.733047,"median":-2.009158,"eighty":-0.994514,"marketCap":27684148},{"date":"2025-03-14","current":-1.466241,"twenty":-3.715671,"median":-2.000609,"eighty":-1.009999,"marketCap":30876098},{"date":"2025-03-21","current":-1.446017,"twenty":-3.689606,"median":-1.999683,"eighty":-1.013274,"marketCap":30450221},{"date":"2025-03-28","current":-1.400513,"twenty":-3.672229,"median":-1.987785,"eighty":-1.023996,"marketCap":29491997},{"date":"2025-04-04","current":-1.413105,"twenty":-3.646165,"median":-1.97496,"eighty":-1.052949,"marketCap":29385528},{"date":"2025-04-11","current":-1.292212,"twenty":-3.632473,"median":-1.960684,"eighty":-1.07647,"marketCap":26871539},{"date":"2025-04-17","current":-1.353745,"twenty":-3.624044,"median":-1.957861,"eighty":-1.119315,"marketCap":28151137},{"date":"2025-04-25","current":-1.497325,"twenty":-3.576659,"median":-1.932212,"eighty":-1.140737,"marketCap":31136863},{"date":"2025-05-02","current":-1.415279,"twenty":-3.547698,"median":-1.895465,"eighty":-1.183582,"marketCap":29430734},{"date":"2025-05-09","current":-1.660424,"twenty":-3.533217,"median":-1.879806,"eighty":-1.205004,"marketCap":32416460},{"date":"2025-05-16","current":-1.813358,"twenty":-3.402894,"median":-1.836381,"eighty":-1.205004,"marketCap":35402187},{"date":"2025-05-23","current":-1.818819,"twenty":-3.394674,"median":-1.835205,"eighty":-1.205004,"marketCap":35508803},{"date":"2025-05-30","current":-1.747814,"twenty":-3.389431,"median":-1.825702,"eighty":-1.219999,"marketCap":34122574},{"date":"2025-06-06","current":-1.518413,"twenty":-3.356664,"median":-1.812937,"eighty":-1.238744,"marketCap":29643986},{"date":"2025-06-13","current":-1.573033,"twenty":-3.347546,"median":-1.780586,"eighty":-1.263722,"marketCap":30710316},{"date":"2025-06-20","current":-1.529337,"twenty":-3.328513,"median":-1.769663,"eighty":-1.282939,"marketCap":29857252},{"date":"2025-06-27","current":-1.616728,"twenty":-3.316033,"median":-1.747814,"eighty":-1.298365,"marketCap":31563381},{"date":"2025-07-03","current":-1.715043,"twenty":-3.313411,"median":-1.723235,"eighty":-1.304149,"marketCap":33482776},{"date":"2025-07-11","current":-1.573033,"twenty":-3.306858,"median":-1.704119,"eighty":-1.309092,"marketCap":30710316},{"date":"2025-07-18","current":-1.857052,"twenty":-3.287198,"median":-1.709581,"eighty":-1.313499,"marketCap":36255235},{"date":"2025-07-25","current":-1.780586,"twenty":-3.245255,"median":-1.731428,"eighty":-1.315637,"marketCap":34762372},{"date":"2025-08-01","current":-1.59499,"twenty":-3.202003,"median":-1.709581,"eighty":-1.320129,"marketCap":31138981},{"date":"2025-08-08","current":-1.501054,"twenty":-3.162393,"median":-1.704119,"eighty":-1.324673,"marketCap":31921424},{"date":"2025-08-15","current":-1.477502,"twenty":-3.138365,"median":-1.693195,"eighty":-1.327278,"marketCap":31420560},{"date":"2025-08-22","current":-1.194146,"twenty":-3.128333,"median":-1.671347,"eighty":-1.320129,"marketCap":25394699},{"date":"2025-08-29","current":-1.224505,"twenty":-3.101702,"median":-1.663591,"eighty":-1.304149,"marketCap":26040327},{"date":"2025-09-05","current":-1.366183,"twenty":-3.081429,"median":-1.660423,"eighty":-1.303066,"marketCap":29053258},{"date":"2025-09-12","current":-1.345944,"twenty":-3.066949,"median":-1.654962,"eighty":-1.296769,"marketCap":28622839},{"date":"2025-09-19","current":-1.386423,"twenty":-3.046676,"median":-1.647118,"eighty":-1.303066,"marketCap":29483676},{"date":"2025-09-26","current":-0.861202,"twenty":-3.000339,"median":-1.627652,"eighty":-1.286622,"marketCap":18314313},{"date":"2025-10-03","current":-0.845878,"twenty":-2.950172,"median":-1.616728,"eighty":-1.242943,"marketCap":17988436},{"date":"2025-10-10","current":-1.062637,"twenty":-2.928517,"median":-1.616728,"eighty":-1.223899,"marketCap":22598047},{"date":"2025-10-17","current":-0.951682,"twenty":-2.892682,"median":-1.595445,"eighty":-1.196318,"marketCap":20238478},{"date":"2025-10-24","current":-1.109127,"twenty":-2.848224,"median":-1.586287,"eighty":-1.167745,"marketCap":23586701},{"date":"2025-10-31","current":-1.009744,"twenty":-2.838158,"median":-1.578799,"eighty":-1.137564,"marketCap":21473218},{"date":"2025-11-07","current":-0.979268,"twenty":-2.827567,"median":-1.573033,"eighty":-1.09575,"marketCap":20825121},{"date":"2025-11-14","current":-0.874336,"twenty":-2.782179,"median":-1.55917,"eighty":-1.068311,"marketCap":19050025},{"date":"2025-11-21","current":-0.921147,"twenty":-2.751616,"median":-1.548341,"eighty":-1.04304,"marketCap":20069955},{"date":"2025-11-28","current":-1.108759,"twenty":-2.677786,"median":-1.547831,"eighty":-1.029836,"marketCap":24157640},{"date":"2025-12-05","current":-1.117347,"twenty":-2.658929,"median":-1.540058,"eighty":-1.041364,"marketCap":24344752},{"date":"2025-12-12","current":-1.100039,"twenty":-2.607631,"median":-1.529337,"eighty":-1.049746,"marketCap":23967649},{"date":"2025-12-19","current":-0.924847,"twenty":-2.607631,"median":-1.528971,"eighty":-1.028153,"marketCap":20150557},{"date":"2025-12-26","current":-0.990114,"twenty":-2.593952,"median":-1.522275,"eighty":-1.014932,"marketCap":21572611},{"date":"2026-01-02","current":-0.873452,"twenty":-2.585402,"median":-1.518124,"eighty":-1.009626,"marketCap":19030762},{"date":"2026-01-09","current":-0.912956,"twenty":-2.566593,"median":-1.509376,"eighty":-0.990834,"marketCap":19891479},{"date":"2026-01-16","current":-0.886796,"twenty":-2.536019,"median":-1.505215,"eighty":-0.983473,"marketCap":19321506},{"date":"2026-01-23","current":-0.88521,"twenty":-2.488199,"median":-1.499762,"eighty":-0.971998,"marketCap":19286962},{"date":"2026-01-30","current":-0.879661,"twenty":-2.42179,"median":-1.497742,"eighty":-0.956952,"marketCap":19166059},{"date":"2026-02-06","current":-0.700241,"twenty":-2.383454,"median":-1.496567,"eighty":-0.949434,"marketCap":15256850},{"date":"2026-02-13","current":-0.69271,"twenty":-2.358396,"median":-1.490148,"eighty":-0.939766,"marketCap":15092767},{"date":"2026-02-20","current":-2.59352,"twenty":-2.420786,"median":-1.496566,"eighty":-0.941348,"marketCap":56507615}],"updateTime":1771922620465},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COCH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2613711120","title":"Envoy Medical Regains Nasdaq Listing Compliance Under Rule 5550(b)","url":"https://stock-news.laohu8.com/highlight/detail?id=2613711120","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613711120?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:02","pubTimestamp":1771938160,"startTime":"0","endTime":"0","summary":"Envoy Medical said it has regained compliance with Nasdaq’s continued listing requirements after previously receiving a notice that it fell below the $35 million minimum Market Value of Listed Securities threshold. Nasdaq confirmed the company met the requirement through alternative standards, and Envoy said it plans to maintain compliance to remain listed on the Nasdaq Capital Market.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL8ZLJr4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCH","BK4082"],"gpt_icon":0},{"id":"2613782882","title":"Envoy Medical Secures Three New Patents for Fully Implanted Cochlear Implant Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2613782882","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613782882?lang=en_us&edition=fundamental","pubTime":"2026-02-23 21:03","pubTimestamp":1771851810,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. said three new patents were issued, including one U.S. patent  covering improved input signal-to-noise ratio processing for cochlear implant systems and two Hong Kong patents: HK40102155 on coordinating a cochlear implant with an external auditory aid by adjusting the processor transfer function, and HK40107235 on electrode impedance diagnostics used to set stimulation parameters such as compliance voltage. The company said the additions expand its intellectual property portfolio and strengthen its competitive position in fully implanted hearing solutions.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDL5yzBDW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","COCH"],"gpt_icon":0},{"id":"2612407009","title":"Envoy Medical Hosts Fireside Chat With Cochlear Implant Surgeon Theodore McRackan","url":"https://stock-news.laohu8.com/highlight/detail?id=2612407009","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612407009?lang=en_us&edition=fundamental","pubTime":"2026-02-19 21:02","pubTimestamp":1771506133,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief on February 19, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDLbnZLxR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCH","BK4082"],"gpt_icon":0},{"id":"2612406400","title":"Glen Taylor Buys 241% More Envoy Medical Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2612406400","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612406400?lang=en_us&edition=fundamental","pubTime":"2026-02-19 18:14","pubTimestamp":1771496067,"startTime":"0","endTime":"0","summary":"Envoy Medical, Inc. ( NASDAQ:COCH ) shareholders (or potential shareholders) will be happy to see that insider Glen...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-coch/envoy-medical/news/glen-taylor-buys-241-more-envoy-medical-shares","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-coch/envoy-medical/news/glen-taylor-buys-241-more-envoy-medical-shares","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["COCH","BK4082"],"gpt_icon":0},{"id":"2612493236","title":"Envoy Medical Director Mona Chetan Patel Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2612493236","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612493236?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:52","pubTimestamp":1771365164,"startTime":"0","endTime":"0","summary":"Mona Chetan Patel, Director, reported the acquisition of common shares of Envoy Medical Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 17, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL72KzCf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Envoy Medical Director Mona Chetan Patel Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","COCH"],"gpt_icon":0},{"id":"2612934214","title":"Interim CFO Robert Potashnick Acquires Common Shares of Envoy Medical Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2612934214","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612934214?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:50","pubTimestamp":1771365037,"startTime":"0","endTime":"0","summary":"Robert Potashnick, Interim CFO, reported the acquisition of common shares of Envoy Medical Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 17, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL5kmlLQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCH","BK4082"],"gpt_icon":0},{"id":"2612485493","title":"Envoy Medical Director Susan Kantor Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2612485493","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612485493?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:48","pubTimestamp":1771364904,"startTime":"0","endTime":"0","summary":"Susan Kantor, a director of Envoy Medical Inc., reported the acquisition of Class A common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 17, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL25sfcl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCH","BK4082"],"gpt_icon":0},{"id":"2612493112","title":"Envoy Medical CEO Brent T. Lucas Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2612493112","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612493112?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:46","pubTimestamp":1771364769,"startTime":"0","endTime":"0","summary":"Brent T. Lucas, Chief Executive Officer of Envoy Medical Inc., reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 17, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL7VVD6F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Envoy Medical CEO Brent T. Lucas Acquires Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","COCH"],"gpt_icon":0},{"id":"2612445214","title":"Envoy Medical Nears Full Enrollment in Pivotal Acclaim Cochlear Implant Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2612445214","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612445214?lang=en_us&edition=fundamental","pubTime":"2026-02-17 21:04","pubTimestamp":1771333465,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. has announced continued progress in enrollment for its pivotal clinical trial of the fully implanted Acclaim cochlear implant. To date, 45 out of a planned 56 patients have been implanted and enrolled, with full enrollment expected by the end of March 2026. The company anticipates completing the trial and potentially submitting for Premarket Approval  to the U.S. FDA in the second quarter of 2027. Envoy Medical expects to provide an update on the trial at an industry meeting in May 2026. Results from the study have not yet been formally presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief on February 17, 2026, and is solely respon","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL492dKy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","COCH"],"gpt_icon":0},{"id":"2611705129","title":"Envoy Medical Raises $30 Million in Public Offering With Warrants for Up to $48 Million More","url":"https://stock-news.laohu8.com/highlight/detail?id=2611705129","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611705129?lang=en_us&edition=fundamental","pubTime":"2026-02-13 05:10","pubTimestamp":1770930617,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. has announced the closing of its previously upsized public offering, which included the issuance of 75,000,000 shares of its Class A common stock , accompanied by Series A-1 and Series A-2 common warrants to purchase up to 45,000,000 and 75,000,000 shares of Class A common stock, respectively. The offering raised approximately $30 million in gross proceeds upfront, with the potential for an additional $48 million if all milestone-linked warrants are exercised for cash. The proceeds will be used to fund operations during the company's FDA pivotal clinical study and extend its cash runway into the second half of 2027, or further if the warrants are fully exercised.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy M","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nNDL4nPsN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCH","BK4082"],"gpt_icon":0},{"id":"2610596540","title":"Envoy Medical Awards Stock Options to CEO and Interim CFO at $0.53 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2610596540","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610596540?lang=en_us&edition=fundamental","pubTime":"2026-02-12 05:01","pubTimestamp":1770843700,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. has approved new stock option awards for its Chief Executive Officer, Brent Lucas, and Interim Chief Financial Officer, Robert Potashnick. Under the company's 2023 Equity Incentive Plan, Mr. Lucas received options to purchase 200,000 shares of Class A Common Stock, while Mr. Potashnick received options for 15,000 shares. The options carry an exercise price of $0.53 per share, reflecting the closing price on February 5, 2026. Vesting terms stipulate that 25% of the options vest after one year, with the remaining options vesting pro rata over the following 36 months. The options will expire 10 years from the award date.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content use","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDL59Zddg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCH","BK4082"],"gpt_icon":0},{"id":"2610554689","title":"Envoy Medical Announces Upsized Offering With Warrants for Up to $48 Million in Additional Proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2610554689","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610554689?lang=en_us&edition=fundamental","pubTime":"2026-02-11 22:25","pubTimestamp":1770819958,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. has announced the pricing of an upsized public offering, raising approximately $30 million upfront through the sale of 75 million shares of its Class A common stock , accompanied by Series A-1 and Series A-2 common warrants. The Series A-1 warrants allow the purchase of up to 45 million shares, and the Series A-2 warrants allow the purchase of up to 75 million shares, both at a combined offering price of $0.40 per share. If fully exercised for cash, these milestone-linked warrants could generate up to an additional $48 million in gross proceeds for the company. Envoy Medical plans to use the funds for working capital, general corporate purposes, and to support its ongoing FDA pivotal clinical study.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDL4jC4wS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","COCH"],"gpt_icon":0},{"id":"2607080710","title":"Envoy Medical to Present at Small Cap Growth Virtual Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2607080710","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607080710?lang=en_us&edition=fundamental","pubTime":"2026-01-29 21:35","pubTimestamp":1769693716,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. will participate in the Small Cap Growth Virtual Investor Conference on February 5, 2026. The company’s management is scheduled to present at 10:00 A.M. ET, followed by a live question-and-answer session. A recording of the presentation will be made available on Envoy Medical’s Investor Relations website after the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via GlobeNewswire  on January 29, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nNDL9pSxsf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","SG9999014013.SGD","LU2210149790.SGD","COCH","BK4585","SG9999014021.USD","LU2210150020.SGD","IE00BKPKM429.USD","SG9999014039.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU0314104364.USD","BK4082","BK4112","NDAQ","SG9999014005.SGD","LU2095319765.USD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2592906544","title":"Envoy Medical Hits Enrollment Milestone in Pivotal Acclaim Cochlear Implant Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2592906544","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592906544?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:02","pubTimestamp":1766062963,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. announced that its pivotal clinical study for the investigational fully implanted Acclaim cochlear implant has reached the midway point of its full enrollment target. The company reports that enrollment is progressing steadily and remains on track for completion within the first half of the first quarter of 2026. The Acclaim cochlear implant is designed to utilize a proprietary implanted piezoelectric sensor to capture sound through the natural ear, rather than relying on an external microphone. Results from the pivotal study have not yet been presented and are expected to be available following the completion of enrollment and subsequent phases of the trial.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medic","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL9fBMFB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","COCH"],"gpt_icon":0},{"id":"2591982826","title":"Envoy Medical Secures Australian Patent for Fully Implanted Cochlear Implant Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2591982826","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591982826?lang=en_us&edition=fundamental","pubTime":"2025-12-16 21:03","pubTimestamp":1765890239,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. has announced the issuance of Australian Patent No. 2022229818, granted by the Australian Patent Office on October 16, 2025. The new patent is aimed at enhancing the input signal-to-noise ratio in cochlear implant technology and further strengthens the company's global intellectual property portfolio. The company stated that it remains committed to establishing and protecting its competitive advantages within the hearing health industry.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via Newsfile  on December 16, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDL5vRK5P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCH","BK4082"],"gpt_icon":0},{"id":"2590458207","title":"Envoy Medical Activates First Patients in Pivotal Trial of Fully Implanted Acclaim Cochlear Implant","url":"https://stock-news.laohu8.com/highlight/detail?id=2590458207","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590458207?lang=en_us&edition=fundamental","pubTime":"2025-12-10 21:01","pubTimestamp":1765371697,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. has announced the completion of the first set of activations in the final stage of its pivotal clinical study for the investigational fully implanted Acclaim cochlear implant. The activations took place at Shohet Ear Associates in Seal Beach, California, and the Center for Neurosciences Ear and Hearing Center in Tucson, Arizona, which are among the seven investigational sites involved in the study. No serious adverse events were reported during these initial activations. Specific hearing results from the clinical study have not yet been disclosed and will be presented after the trial is completed. Full enrollment for the pivotal trial is expected in early 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Med","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nNDL1Dnkf8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCH","BK4082"],"gpt_icon":0},{"id":"2588021149","title":"Envoy Medical Inc. Held Special Meeting of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2588021149","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588021149?lang=en_us&edition=fundamental","pubTime":"2025-12-04 05:02","pubTimestamp":1764795726,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. held a Special Meeting of Stockholders on November 26, 2025. Stockholders approved the issuance of warrants to purchase shares of Class A Common Stock and the issuance of shares underlying those warrants, as outlined in a securities purchase agreement and an engagement letter with H.C. Wainwright & Co., LLC. Additionally, an administrative proposal allowing adjournment of the meeting, if necessary, was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 03, 2025, and is solely responsi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDLNhc0b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCH","BK4082"],"gpt_icon":0},{"id":"2588305328","title":"Envoy Medical Inc. Granted 40th U.S. Patent for Fully Implanted Hearing Device Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2588305328","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588305328?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:03","pubTimestamp":1764680582,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. has announced the grant of its 40th active U.S. patent, further strengthening its intellectual property portfolio. The company also holds 45 issued foreign patents. The newly granted U.S. Patent No. 12,485,288 covers proprietary cochlear implant systems designed to enhance performance and reliability, enabling real-time measurement and adjustment of electrical current delivered from the implant's stimulator to the auditory nerve.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via Newsfile  on December 02, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL6LYhns:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCH","BK4082"],"gpt_icon":0},{"id":"2586406038","title":"Envoy Medical Faces Nasdaq Delisting Risk Over Minimum Bid Price Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2586406038","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586406038?lang=en_us&edition=fundamental","pubTime":"2025-11-26 05:02","pubTimestamp":1764104558,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. has received a notice from the Nasdaq Stock Market indicating that its Class A Common Stock has failed to meet the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. The company has 180 calendar days, until May 18, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 per share for ten consecutive business days. If it does not meet this requirement, Envoy Medical may be eligible for an additional 180-day compliance period, provided it meets other listing standards and notifies Nasdaq of its plan to address the deficiency, potentially through a reverse stock split. If compliance is not achieved, the company could face delisting, though it would have the option to appeal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL9kGpdD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","COCH"],"gpt_icon":0},{"id":"2584748131","title":"Envoy Medical Granted U.S. Patent for Innovative Cochlear Implant System with Removable Earplug Sensor and Implanted Battery","url":"https://stock-news.laohu8.com/highlight/detail?id=2584748131","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584748131?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:01","pubTimestamp":1763643705,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. announced the issuance of U.S. Patent No. 12,465,754 for its innovative cochlear implant system featuring a removable earplug sensor and an implanted battery. The patent covers a combination implant system where an implantable subsystem, including a stimulator and rechargeable energy storage, works with a removable earplug equipped with a sensor and signal processor. This development expands the company's intellectual property portfolio and reinforces its position in next-generation cochlear implant technology.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via Newsfile  on November 20, 2025, and is solely responsible for the informati","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDL3SG1Gg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCH","BK4082"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":43,"code":"91000000","status":"200"}]}}